Steinberganna Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
959
+21
+2% +$21.5K 0.47% 40
2026
Q1
$862K Buy
938
+5
+0.5% +$5.07K 0.41% 41
2025
Q4
$1M Buy
933
+8
+0.9% +$7.65K 0.47% 39
2025
Q3
$706K Buy
+925
New +$688K 0.33% 50

Other funds holding LLY

Steinberganna Wealth Management's LLY Position: Q2 2026 in Review

Steinberganna Wealth Management increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $21.5K and bringing the position to 959 shares worth $1.15M. The position accounts for 0.47% of the portfolio, ranked #40.

Steinberganna Wealth Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steinberganna Wealth Management held 959 shares of Eli Lilly worth $1.15M as of Q2 2026.
  • Steinberganna Wealth Management bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.47% of Steinberganna Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Steinberganna Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Steinberganna Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.